ATE480558T1 - Auf scf peptid basiertes basolaterales sortiersignal und inhibitoren dafür - Google Patents

Auf scf peptid basiertes basolaterales sortiersignal und inhibitoren dafür

Info

Publication number: ATE480558T1
Authority: AT; Austria
Prior art keywords: sub; amino acid; inhibitors; sorting signal; peptide based
Prior art date: 1999-12-23

Application number

AT00988804T

Other languages

English (en)

Inventor

Bernhard Wehrle-Haller

Beat Imhof

Original Assignee

Univ Geneve

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-23

Filing date

2000-12-22

Publication date

2010-09-15

2000-12-22 Application filed by Univ Geneve filed Critical Univ Geneve

2010-09-15 Application granted granted Critical

2010-09-15 Publication of ATE480558T1 publication Critical patent/ATE480558T1/de

Links

239000003112 inhibitor Substances 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1
125000000539 amino acid group Chemical group 0.000 abstract 4
150000001413 amino acids Chemical group 0.000 abstract 2
230000002209 hydrophobic effect Effects 0.000 abstract 2
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
235000004279 alanine Nutrition 0.000 abstract 1
229940024606 amino acid Drugs 0.000 abstract 1
235000001014 amino acid Nutrition 0.000 abstract 1
230000001419 dependent effect Effects 0.000 abstract 1
229960000310 isoleucine Drugs 0.000 abstract 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 abstract 1
125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Toxicology (AREA)
Dermatology (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Physical Education & Sports Medicine (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Birds (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Pregnancy & Childbirth (AREA)
Hematology (AREA)
Gynecology & Obstetrics (AREA)
Oncology (AREA)
Diabetes (AREA)
Peptides Or Proteins (AREA)
Investigating Or Analysing Biological Materials (AREA)

AT00988804T 1999-12-23 2000-12-22 Auf scf peptid basiertes basolaterales sortiersignal und inhibitoren dafür ATE480558T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH9900624		1999-12-23
PCT/EP2000/013141 WO2001047950A2 (en)	1999-12-23	2000-12-22	Basolateral sorting signal based on scf peptide and inhibitors thereof

Publications (1)

Publication Number	Publication Date
ATE480558T1 true ATE480558T1 (de)	2010-09-15

Family

ID=42676692

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00988804T ATE480558T1 (de)	1999-12-23	2000-12-22	Auf scf peptid basiertes basolaterales sortiersignal und inhibitoren dafür

Country Status (8)

Country	Link
US (1)	US7033794B2 (de)
EP (1)	EP1240196B1 (de)
JP (1)	JP2003518929A (de)
AT (1)	ATE480558T1 (de)
AU (1)	AU2511901A (de)
CA (1)	CA2395236A1 (de)
DE (1)	DE60044945D1 (de)
WO (1)	WO2001047950A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7102055B1 (en) *	1997-11-18	2006-09-05	Pioneer Hi-Bred International, Inc.	Compositions and methods for the targeted insertion of a nucleotide sequence of interest into the genome of a plant
WO2003002108A2 (en)	2001-06-29	2003-01-09	Ab Science	Use of tyrosine kinase inhibitors for treating inflammatory diseases
CA2452371A1 (en)	2001-06-29	2003-01-09	Ab Science	Use of tyrosine kinase inhibitors for treating allergic diseases
JP2005500041A (ja)	2001-06-29	2005-01-06	アブサイエンス	強力で選択的かつ非毒性のｃ−ｋｉｔ阻害剤
US7678805B2 (en)	2001-06-29	2010-03-16	Ab Science	Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (IBD)
JP2005511596A (ja) *	2001-09-20	2005-04-28	アブサイエンス	ヒトの皮膚を白くし、且つメラノサイト機能不全関連疾病を治療するためのチロシンキナーゼ阻害剤の使用方法
RU2295970C1 (ru)	2006-05-23	2007-03-27	Общество С Ограниченной Ответственностью "Сиа Пептайдс"	Пептид, повышающий резистентность капилляров, фармацевтическая композиция на его основе и способ ее применения
RU2304444C1 (ru)	2006-05-23	2007-08-20	Общество С Ограниченной Ответственностью "Сиа Пептайдс"	Пептид, обладающий стресспротекторным действием, фармацевтическая композиция на его основе и способ ее применения
RU2301678C1 (ru) *	2006-05-30	2007-06-27	Общество С Ограниченной Ответственностью "Сиа Пептайдс"	Пептид, стимулирующий регенерацию нейронов центральной нервной системы, фармацевтическая композиция на его основе и способ ее применения
RU2301074C1 (ru)	2006-05-30	2007-06-20	Общество С Ограниченной Ответственностью "Сиа Пептайдс"	Пептид, обладающий иммуногеропротекторным действием, фармацевтическая композиция на его основе и способ ее применения
JP2020531002A (ja) *	2017-08-15	2020-11-05	キンドレッドバイオサイエンシズインコーポレイテッド	獣医学用ｉｇｇｆｃ変異体
JP2023516010A (ja) *	2020-02-25	2023-04-17	シムビーボコーポレイション	遺伝子送達システム

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1241258A3 (de) *	1989-10-16	2003-12-10	Amgen Inc.	Stamzellfaktor
US6248319B1 (en) *	1989-10-16	2001-06-19	Krisztina M. Zsebo	Method for increasing hematopoietic progenitor cells by stem cell factor polypeptides
US5885962A (en) *	1996-04-05	1999-03-23	Amgen Inc.	Stem cell factor analog compositions and method
US6248326B1 (en) *	1997-09-10	2001-06-19	Harry C. Blair	Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
AU2001263006A1 (en) *	2000-05-18	2001-11-26	Hyseq, Inc.	Novel nucleic acids and polypeptides

2000
- 2000-12-22 AU AU25119/01A patent/AU2511901A/en not_active Abandoned
- 2000-12-22 AT AT00988804T patent/ATE480558T1/de not_active IP Right Cessation
- 2000-12-22 CA CA002395236A patent/CA2395236A1/en not_active Abandoned
- 2000-12-22 JP JP2001549420A patent/JP2003518929A/ja active Pending
- 2000-12-22 DE DE60044945T patent/DE60044945D1/de not_active Expired - Lifetime
- 2000-12-22 WO PCT/EP2000/013141 patent/WO2001047950A2/en not_active Ceased
- 2000-12-22 EP EP00988804A patent/EP1240196B1/de not_active Expired - Lifetime
2002
- 2002-06-20 US US10/176,791 patent/US7033794B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP2003518929A (ja)	2003-06-17
WO2001047950A3 (en)	2002-01-17
EP1240196A2 (de)	2002-09-18
AU2511901A (en)	2001-07-09
CA2395236A1 (en)	2001-07-05
DE60044945D1 (de)	2010-10-21
US7033794B2 (en)	2006-04-25
US20030237101A1 (en)	2003-12-25
EP1240196B1 (de)	2010-09-08
WO2001047950A2 (en)	2001-07-05

Legal Events

Date	Code	Title	Description
2011-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
PT794961E (pt)	2003-01-31	Peptideos antagonistas de lhrh
EP1803733A3 (de)	2007-10-31	Behandlung von Entzündungen
PL347932A1 (en)	2002-04-22	Interferon-beta fusion proteins and uses
ATE480558T1 (de)	2010-09-15	Auf scf peptid basiertes basolaterales sortiersignal und inhibitoren dafür
AU2002217010A1 (en)	2002-05-21	Peptides, the production and use thereof for binding immunoglobulins
DE69613137D1 (de)	2001-07-05	Zyklische peptidanaloga von somatostatin
DK1908772T3 (da)	2012-03-19	Polypeptider og polynucleinsyrer af phorphorymonas gingivalis
EP1006126A3 (de)	2000-10-25	Peptide mit osteogener Aktivität
DK1012175T3 (da)	2003-04-28	Peptid med affinitet til koagulationsfaktor VIII
BR9711540A (pt)	2001-06-19	Inibidores de protease proteìnico estabilizados e variantes dos mesmos
BR9714376A (pt)	2000-03-21	Antagonistas de somatostatina
DE69938130D1 (de)	2008-03-27	Neue peptide
DE60329115D1 (de)	2009-10-15	Tumorantigenprotein und dessen verwendung
WO2001042287A3 (en)	2002-02-14	Putative human g-protein coupled receptors
DK1504036T3 (da)	2011-10-24	Toxinrelaterede fragmenter af antistoffer med antimikrobiel og antiviral aktivitet
ATE353913T1 (de)	2007-03-15	Neue collectine
DE60135489D1 (de)	2008-10-02	Lactam dipeptid und dessen verwendung zur inhibierung der beta-amyloid peptid frisetzung
WO2001025430A3 (en)	2001-10-18	Novel human membrane proteins
GB2361923A (en)	2001-11-07	Novel protein
AU4956901A (en)	2001-10-08	Novel human 7tm proteins and polynucleotides encoding the same